← Longevity

Evidence-based · Longevity

High Alkaline Phosphatase: What ALP Elevation Points To

ALP comes from bone and liver in roughly equal share. One extra test tells you which — and the mortality data starts inside the normal range.

Evidence: Moderate
Part ofThe Longevity Guide

Alkaline phosphatase is grouped with the liver enzymes on a standard panel, which is only half right. ALP is an enzyme family, and in a healthy adult roughly as much of it comes from bone as from liver.

That single fact resolves most of the confusion around a raised result.

Where does ALP come from?

There are four main isoenzymes — bone, liver, intestinal, and placental. About 95% of total serum ALP activity comes from bone and liver, in a ratio of approximately 1:1 in healthy adults.

So an isolated high ALP is genuinely ambiguous in a way that ALT is not. The enzyme is doing different jobs in two different tissues, and the number does not say which one is responsible.

The most common causes of elevation in adults are hepatobiliary disease, bone disease, and pregnancy — placental ALP rises normally in the third trimester.

How do you tell bone from liver?

With GGT — gamma-glutamyl transferase — which is often already on the panel or is the obvious next test.

GGT is present in liver, kidney, pancreas, spleen, heart, brain, and seminal vesicles, but not in bone. It therefore does not rise in skeletal disease. That asymmetry makes it a clean discriminator:

ALPGGTPoints towards
HighHighHepatobiliary — bile duct obstruction, cholestasis, liver disease
HighNormalBone — or a physiological cause such as pregnancy or adolescent growth

A high ALP with a normal GGT is not a liver result, however the panel groups it. That one pairing removes most of the ambiguity before any imaging is ordered.

This is why “elevated liver enzymes” is a slightly misleading phrase when ALP is the enzyme in question.

Does ALP predict mortality?

This is where ALP separates from most of the other indices on a routine panel — and the distinction matters.

Markers like MPV and MCV have prognostic data drawn almost entirely from acutely ill hospital cohorts, which is why it does not transfer to a well adult. ALP has general-population data.

A 2023 analysis in Frontiers in Endocrinology used NHANES data from 1999 to 2014, covering 34,147 adults, and compared ALP quartiles:

QuartileALPAll-cause mortality (vs Q1)Cardiovascular mortality (vs Q1)
Q1≤55 U/Lreferencereference
Q255–67 U/L
Q367–82 U/LHR 1.23 (1.11–1.36)HR 1.33 (1.11–1.59)
Q4>82 U/LHR 1.30 (1.17–1.44)HR 1.39 (1.16–1.66)

The association was non-linear rather than a straight dose-response line.

Why the third quartile is the interesting one

Q3 runs from 67 to 82 U/L. Most laboratory reference ranges have an upper limit well above that — commonly around 120 U/L — so an ALP of 75 is reported as unremarkable and flagged by nothing.

Yet Q3 already carried a 23% higher all-cause mortality and a 33% higher cardiovascular mortality than the bottom quartile.

This is the same structural point that shows up with liver enzyme reference ranges: “within normal limits” describes your position in a laboratory’s reference population, not a threshold where risk begins. It is observational data, so it establishes association rather than causation — a higher ALP may be reporting on underlying metabolic or bone or hepatic processes rather than causing anything itself.

Frequently asked questions

What is a normal alkaline phosphatase level?

Laboratory ranges commonly extend to around 120 U/L in adults, but they vary. Worth knowing separately: in the NHANES analysis, the lowest-mortality quartile was ≤55 U/L, well below most lab ceilings.

What does high alkaline phosphatase mean?

That ALP is entering the blood faster than usual from bone, liver, or — in pregnancy — placenta. Because bone and liver contribute roughly equally in healthy adults, the number alone does not identify the source. GGT is the usual next step.

Is high ALP always a liver problem?

No, and this is the most common misreading. Bone contributes about half of circulating ALP in a healthy adult. A high ALP with a normal GGT points away from the liver.

Can exercise or growth raise ALP?

Bone turnover raises it, which is why adolescents in growth spurts have ALP levels that would be abnormal in an adult. Healing fractures raise it too. These are physiological, not pathological.

Should I be worried about an ALP of 75?

That is inside the normal range on essentially every lab report, and it is not a reason for alarm. It is worth knowing that in the NHANES cohort that band carried modestly higher mortality than the lowest quartile — a population-level association, not a prediction about an individual, and a reason to look at the trend rather than a single value.

The takeaway

ALP is best understood as two enzymes reported as one number. Bone and liver contribute in roughly equal measure, and GGT is the cheap test that tells you which is responsible — high ALP with normal GGT is a skeletal finding, not a hepatic one.

The mortality data is unusual for this panel in coming from a general population rather than from hospital cohorts, and its most useful feature is where the signal starts: inside the reference range, at values no laboratory would flag. That is an argument for reading ALP as a position on a distribution and watching its trend, not for acting on any single result. Which result matters, and what to do about it, is a conversation for a clinician with the whole panel in front of them.

Sources

References

  1. Association of serum alkaline phosphatase level with all-cause and cardiovascular mortality in the general population. Frontiers in Endocrinology 2023 (PMC)
  2. Evaluation of Elevated Liver Enzymes. (PMC)

Stay current

Get evidence-based briefings in your inbox.